GlycoNex (ROCO:4168) Marketable Securities: NT$132.76 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4168 GlycoNex Inc ROCO:4168
55 GF Score
Price NT$22.45
GF Value NT$36.13
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is GlycoNex Marketable Securities?

GlycoNex ROCO:4168 -1.54% 55 Marketable Securities is NT$132.76 Mil as of Jun. 2026. GuruFocus rates ROCO:4168 with a GF Score™ of 55/100 and a GF Value™ of NT$36.13 (Possible Value Trap). The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. GlycoNex's Marketable Securities for the quarter that ended in Jun. 2026 was NT$132.76 Mil.

GlycoNex's annual Marketable Securities declined from Dec. 2023 (NT$550.31 Mil) to Dec. 2024 (NT$332.60 Mil) and declined from Dec. 2024 (NT$332.60 Mil) to Dec. 2025 (NT$225.60 Mil).

GlycoNex  (ROCO:4168) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

GlycoNex Marketable Securities Related Terms

GlycoNex Marketable Securities Historical Data

* Premium members only.

The historical data trend for GlycoNex's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlycoNex Marketable Securities Chart

GlycoNex Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 206.53 596.58 550.31 332.60 225.60

GlycoNex Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 223.10 175.60 225.60 214.00 132.76
ROCO:4168
55GF Score
GlycoNex Inc ROCO:4168
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GlycoNex Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of NT$132.76 Mil mean?
GlycoNex (ROCO:4168) has a Marketable Securities of NT$132.76 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on GlycoNex and its competitors.
Is GlycoNex's Marketable Securities too high?
GlycoNex's current Marketable Securities is NT$132.76 Mil. Overall, GlycoNex has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does GlycoNex's Marketable Securities compare to VRTX and REGN?
GlycoNex's Marketable Securities of NT$132.76 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on GlycoNex and its competitors. GlycoNex's current Marketable Securities is NT$132.76 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlycoNex stock overvalued right now?
Based on GuruFocus' analysis, GlycoNex (ROCO:4168) is currently considered Possible Value Trap. The stock's GF Value™ is NT$36.13, compared to a current price of NT$22.45 — trading 37.9% below its estimated fair value. The current Marketable Securities is NT$132.76 Mil. GlycoNex's overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For GlycoNex (ROCO:4168), the current Marketable Securities is NT$132.76 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GlycoNex (ROCO:4168) Overvalued in 2026?

Based on GuruFocus' analysis, GlycoNex stock appears to be undervalued. The current stock price of NT$22.45 is trading 37.9% below its estimated GF Value™ of NT$36.13. GuruFocus considers GlycoNex to be Possible Value Trap.

Key valuation signals for ROCO:4168:

  • Marketable Securities: NT$132.76 Mil
  • GF Value™: NT$36.13 vs. price of NT$22.45 (37.9% below fair value)
  • GF Score™: 55/100 with 3 warning signs

No single metric tells the full story. See the ROCO:4168 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GlycoNex Business Description

Address Section 1, Xintai 5th Road, 8th Floor, No. 97, Xizhi District, New Taipei City, TWN, 221
GlycoNex Inc is a Taiwan-based company engaged in the development of cancer drugs from the combination of glycosphingolipid antigen and human monoclonal antibody technologies. It has a panel of antibodies that targets various carbohydrate antigens. The antibodies are cloned from hybridoma, engineered to improve stability, and can serve as reagents with applications that include ELISA, Western blot, flow cytometry, and TLC immunostaining. The other services provided by the firm include functional evaluation, antibody research, and antibody engineering. It has two reportable segments: antibody new drug, which derives maximum revenue, and exclusive investment. Geographically, the group derives maximum revenue from Taiwan and the rest from Japan.
55GF Score

Get the complete analysis for ROCO:4168

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$22.45
Price
NT$36.13
GF Value